Corient Private Wealth’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.4K Buy
+10,301
New +$65.9K ﹤0.01% 2983
2026
Q1
Sell
-17,252
Closed -$166K 2945
2025
Q4
$166K Buy
+17,252
New +$179K ﹤0.01% 2462
2025
Q2
Sell
-19,011
Closed -$138K 2514
2025
Q1
$138K Buy
19,011
+449
+2% +$3.26K ﹤0.01% 2130
2024
Q4
$128K Buy
+18,562
New +$128K ﹤0.01% 2198
2024
Q3
Sell
-18,155
Closed -$191K 2532
2024
Q2
$191K Buy
+18,155
New +$230K ﹤0.01% 2128
2023
Q4
Sell
-9,998
Closed -$212K 2320
2023
Q3
$212K Buy
+9,998
New +$260K ﹤0.01% 1892

Other funds holding NUS

Corient Private Wealth's NUS Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Nu Skin (NUS) in Q2 2026: 10,301 shares worth $54.4K. The stake represents ﹤0.01% of the portfolio and ranks #2983 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in NUS as recently as Q4 2025.

Corient Private Wealth first reported a position in NUS in Q3 2023 and has held it in 6 quarters since. The position peaked at $212K in Q3 2023. 161 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Corient Private Wealth held 10,301 shares of Nu Skin worth $54.4K as of Q2 2026.
  • Nu Skin was a new Corient Private Wealth position in Q2 2026.
  • Nu Skin made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2983 holding.
  • Corient Private Wealth first reported a position in Nu Skin in Q3 2023 and has held it in 6 quarters since.
  • Corient Private Wealth's Nu Skin position peaked at $212K in Q3 2023.
  • 161 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.